A United Kingdom buyer, with 6 published contracts, worth £57.4m, most recently 3 months ago.
This contract is for the procurement of laboratory equipment, specifically bioreactors, for the clinical manufacturing of advanced cellular therapies that comply with Good Manufacturing Practice (GMP) standards. The equipment will enable semi-automated, closed system processing of cells intended for
